Fusilev Powder For Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Fusilev: Powder for solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LEVOLEUCOVORIN (LEE voe LOO koe VOE rin) is used to prevent or treat the harmful effects of some medicines.

In-Depth Information

Fusilev 50mg Powder for Injection

NDC: 681520101
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Methotrexate Toxicity Prophylaxis, Colorectal Cancer

Storage Information
Protect from light
Store in outer carton when not in use
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Fusilev 50mg Powder for Injection

Reported Side Effects for Fusilev 50mg Powder for Injection

Upset Stomach Incidence:
<8.0%*
Severity: SEVERE
Onset: EARLY
Feeling Sick Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Hair Loss Incidence:
0.3%*
Severity: SEVERE
Onset: DELAYED
Scaly And Itchy Rashes Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Decreased Appetite Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
5.0%*
Severity: SEVERE
Onset: EARLY
Nerve Pain Incidence:
6.3%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
6.3-12.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
6.3%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
6.3%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
6.3%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
6.3%*
Severity: MILD
Onset: EARLY
Typhlitis Incidence:
6.3%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
19.0%*
Severity: SEVERE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fusilev

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5